AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Covalon to Release Q3 Fiscal 2025 Financial Results on August 21, 2025 and Host Conference Call
ByAinvest
Thursday, Aug 14, 2025 7:03 am ET1min read
Covalon Technologies will release its Q3 Fiscal 2025 financial results on August 21, 2025, before markets open. A conference call and webcast will be held at 8:30am ET to discuss the results. To participate, dial 1-800-549-8228 or follow the link provided. Copies of the financial statements and MD&A can be obtained on SEDAR PLUS or Covalon's website. The company is a leading medical device company dedicated to improving patient outcomes through innovative products and technologies.
Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF), a leading medical device company, is set to release its Q3 Fiscal 2025 financial results on Wednesday, August 21, 2025, before markets open. The company will host a conference call and webcast at 8:30 am ET to discuss the results. Investors and financial professionals are encouraged to participate by dialing the toll-free number 1-800-549-8228 or by following the provided link: [https://events.q4inc.com/attendee/481079572](https://events.q4inc.com/attendee/481079572).The conference call and webcast will provide an opportunity for participants to ask questions of Covalon's management during the Q&A session. A recording of the call will be available on Covalon's website under the News & Events section on the Investors tab. Copies of Covalon’s financial statements and Management's Discussion and Analysis (MD&A) can also be obtained on SEDAR PLUS at [www.sedarplus.ca](http://www.sedarplus.ca) or under SEDAR Filings on the Investors tab of Covalon’s website.
Covalon is dedicated to improving patient outcomes through innovative and compassionate medical products and technologies. The company's expertise spans advanced wound care, vascular access, and surgical consumables, with a strong focus on enhancing healing, reducing healthcare-associated infections (HAIs), and protecting skin integrity. The company is listed on the TSX Venture Exchange (COV) and trades on the OTCQX Market (CVALF). For more information about Covalon, visit [www.covalon.com](http://www.covalon.com).
References:
[1] https://www.businesswire.com/news/home/20250814349843/en/Covalon-Announces-Conference-Call-to-Discuss-Third-Quarter-Fiscal-2025-Financial-Results
[2] https://www.stocktitan.net/news/CVALF/covalon-announces-conference-call-to-discuss-third-quarter-fiscal-0p7knubjbx5o.html
[3] https://www.5iresearch.ca/company/tsx-v/COV
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet